psalexa
logo

Biopharmaceuticals Market

Global Biopharmaceuticals Market Size, Share, Development, Growth and Demand Forecast to 2020 – Industry Insights by Type (Monoclonal Antibodies, Recombinant Proteins, Interferon, Colony-Stimulating Factor, Erythropoietin, Recombinant Human Insulin, Vaccines, Growth Hormones, Purified Proteins and others) and by Application (Oncology, Inflammatory and Infectious Diseases, Metabolic Disorders, Neurological Disorders, Cardiovascular Diseases and Others)

Published: October 2015
Report Code: LS10432
Available Format:
Pages: 115

Chapter 1. Research Scope and Methodology

1.1 Market Definition

1.2 Market Scope

1.2.1 Global biopharmaceuticals market breakdown by type

1.2.2 Global biopharmaceuticals market breakdown by application

1.2.3 Global biopharmaceuticals market breakdown by geography

1.3 Research Methodology and Sources

Chapter 2. Executive Summary

2.1 Key Findings

2.2 Research Summary

Chapter 3. Market Outlook

3.1 Introduction

3.2 Market Trend

3.2.1 Outsourcing of research and production of biopharmaceuticals

3.3 Factors Driving the Market and its Impact on Market Forecast            

3.3.1 Increasing prevalence of chronic diseases

3.3.2 Increasing R&D investments

3.3.3 Growing aging population

3.3.4 Technological advancements in biopharmaceuticals

3.3.5 Impact analysis of drivers on market forecast

3.4 Factors Hindering the Market and its Impact on Market Forecast       

3.4.1 High cost of biopharmaceuticals    

3.4.2 Entry of low-cost biosimilars in the market

3.4.3 Side effects associated with biopharmaceutical drugs

3.4.4 Impact analysis of restraints on market forecast

Chapter 4. Global Biopharmaceuticals Market Size and Forecast (2011 – 2020)

4.1 Global Biopharmaceuticals Market Breakdown by type

4.2 Global Biopharmaceuticals Market Breakdown by Application

4.3 Global Biopharmaceuticals Market Breakdown by Region

Chapter 5. Global Biopharmaceuticals Market Breakdown by Type

5.1 Monoclonal Antibodies Market

5.2 Recombinant Human Insulin Market

5.3 Colony Stimulating Factor Market

5.4 Erythropoietin Market

5.5 Vaccines Market

5.6 Growth Hormones Market

5.7 Interferons Market

5.8 Recombinant Proteins Market

5.9 Purified Proteins Market

5.10 Others

Chapter 6. Global Biopharmaceuticals Market Breakdown by Application

6.1 Oncology Biopharmaceuticals Market

6.2 Inflammatory and Infectious Diseases Biopharmaceuticals Market

6.3 Metabolic Disorders Biopharmaceuticals Market       

6.4 Neurological Disorders Biopharmaceuticals Market

6.5 Cardiovascular Diseases Biopharmaceuticals Market

6.5.1 Other Applications

Chapter 7. Global Biopharmaceuticals Market Breakdown by Geography

7.1 North America Biopharmaceuticals Market

7.1.1 North America biopharmaceuticals market breakdown by type

7.1.2 North America biopharmaceuticals market breakdown by application

7.1.3 North America biopharmaceuticals market breakdown by country

7.2 Europe Biopharmaceuticals Market

7.2.1 Europe biopharmaceuticals market breakdown by type

7.2.2 Europe biopharmaceuticals market breakdown by application

7.2.3 Europe biopharmaceuticals market breakdown by country

7.3 Asia  Biopharmaceuticals Market

7.3.1 Asia biopharmaceuticals market breakdown by type

7.3.2 Asia biopharmaceuticals market breakdown by application               

7.3.3 Asia biopharmaceuticals market breakdown by country     

7.4 Rest of the World Biopharmaceuticals Market

7.4.1 Rest of the world biopharmaceuticals market breakdown by type

7.4.2 Rest of the world biopharmaceuticals market breakdown by application

7.4.3 Rest of the world biopharmaceuticals market breakdown by country

Chapter 8. Competitive Analysis and Market Share

8.1 Porter's Five Forces of Competitive Position Analysis

8.1.1 Bargaining power of buyers

8.1.2 Bargaining power of suppliers

8.1.3 Threat of new entrants

8.1.4 Intensity of rivalry

8.1.5 Threat of substitutes

8.2 Market Share Analysis of Major Players

Chapter 9. Company Profiles and Strategic Developments

9.1 Key Company Profiles

9.1.1 AbbVie Inc.

9.1.1.1 Business overview

9.1.1.2 Products and services

9.1.2 Sanofi

9.1.2.1 Business overview

9.1.2.2 Products and services

9.1.3 Eli Lilly and Company

9.1.3.1 Business overview

9.1.3.2 Products and services

9.1.4 Pfizer Inc.

9.1.4.1 Business overview

9.1.4.2 Products and services

9.1.5 Abbott Laboratories

9.1.5.1 Business Overview

9.1.5.2 Products and services

9.1.6 AstraZeneca PLC

9.1.6.1 Business overview

9.1.6.2 Products and services

9.1.7 Novartis AG

9.1.7.1 Business Overview

9.1.7.2 Products and services

9.1.8 Biogen Idec

9.1.8.1 Business overview

9.1.8.2 Products and services

9.1.9 Amgen Inc.

9.1.9.1 Business Overview

9.1.9.2 Products and services

9.1.10 Bristol-Myers Squibb Company

9.1.10.1 Business overview

9.1.10.2 Products and services

9.1.11 Glaxo Smith Kline PLC

9.1.11.1 Business overview

9.1.11.2 Products and services

9.1.12 Johnson & Johnson Services Inc. 

9.1.12.1 Business Overview

9.1.12.2 Products and Services

9.1.13 F. Hoffmann-La Roche Ltd.

9.1.13.1 Business overview

9.1.13.2 Products and services

9.1.14 Merck & Co. Inc.

9.1.14.1 Business overview

9.1.14.2 Products and services

9.1.15 Bayer AG

9.1.15.1 Business overview

9.1.15.2 Products and services

9.2 Strategic Developments in the Global Biopharmaceuticals Market

9.2.1 Mergers & acquisitions

9.2.2 Partnership/Collaboration

9.2.3 Geographical expansion    

9.2.4 Product launch

9.2.5 Others

Chapter 10. Appendix

10.1 List of Abbreviations

 

LIST OF TABLES

TABLE 1 SPECIFIC PRIMARY AND SECONDARY SOURCES USED FOR THIS PUBLICATION

TABLE 2 GLOBAL BIOPHARMACEUTICALS MARKET BREAKDOWN SNAPSHOT

TABLE 3 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 5 GLOBAL BIOPHARMACEUTICALS MARKET BREAKDOWN BY TYPE, $M (2011 – 2014)

TABLE 6 GLOBAL BIOPHARMACEUTICALS MARKET BREAKDOWN BY TYPE, $M (2015 – 2020)

TABLE 7 GLOBAL BIOPHARMACEUTICALS MARKET BREAKDOWN BY APPLICATION, $M (2011 – 2014)

TABLE 8 GLOBAL BIOPHARMACEUTICALS MARKET BREAKDOWN BY APPLICATION, $M (2015 – 2020)

TABLE 9 GLOBAL BIOPHARMACEUTICALS MARKET BREAKDOWN BY REGION, $M (2011 – 2014)

TABLE 10 GLOBAL BIOPHARMACEUTICALS MARKET BREAKDOWN BY REGION, $M (2015 – 2020)

TABLE 11 GLOBAL MONOCLONAL  ANTIBODIES  MARKET BREAKDOWN BY REGION $M (2011-2014)

TABLE 12 GLOBAL MONOCLONAL ANTIBODIES   MARKET  BREAKDOWN BY REGION, $M (2015-2020)

TABLE 13 GLOBAL RECOMBINANT HUMAN INSULIN MARKET  BREAKDOWN BY REGION, $M   (2011 – 2014)

TABLE 14 GLOBAL RECOMBINANT HUMAN INSULIN MARKET  BREAKDOWN BY REGION, $M   (2015 – 2020)

TABLE 15 GLOBAL COLONY STIMULATING FACTOR MARKET BREAKDOWN BY REGION, $M (2011-2014)

TABLE 16 GLOBAL COLONY STIMULATING FACTOR MARKET BREAKDOWN BY REGION, $M (2015-2020)

TABLE 17 GLOBAL ERYTHROPOIETIN  MARKET  BREAKDOWN BY REGION, $M (2011 – 2014)

TABLE 18 GLOBAL ERYTHROPOIETIN MARKET BREAKDOWN BY REGION, $M (2015 – 2020)

TABLE 19 GLOBAL VACCINES MARKET BREAKDOWN BY REGION, $M (2011-2014)

TABLE 20 GLOBAL VACCINES MARKET BREAKDOWN BY REGION, $M (2015-2020)

TABLE 21 GLOBAL GROWTH HORMONES MARKET BREAKDOWN BY REGION, $M (2011-2014)

TABLE 22 GLOBAL GROWTH HORMONES  MARKET BREAKDOWN BY REGION, $M (2015-2020)

TABLE 23 GLOBAL INTERFERONS MARKET BREAKDOWN BY REGION, $M (2011-2014)

TABLE 24 GLOBAL INTERFERONS MARKET BREAKDOWN BY REGION, $M (2015-2020)

TABLE 25 GLOBAL RECOMBINANT PROTEINS  MARKET BREAKDOWN BY REGION, $M (2011-2014)

TABLE 26 GLOBAL RECOMBINANT PROTEINS  MARKET BREAKDOWN BY REGION, $M (2015-2020)

TABLE 27 GLOBAL PURIFIED PROTEINS MARKET  BREAKDOWN BY REGION, $M (2011-2014)

TABLE 28 GLOBAL PURIFIED PROTEINS MARKET  BREAKDOWN BY REGION, $M (2015-2020)

TABLE 29 GLOBAL ONCOLOGY BIOPHARMACEUTICALS  MARKET  BREAKDOWN BY REGION, $M (2011 – 2014)

TABLE 30 GLOBAL  ONCOLOGY BIOPHARMACEUTICALS  MARKET   BREAKDOWN BY REGION, $M (2015 – 2020)

TABLE 31 GLOBAL  INFLAMMATORY AND INFECTIOUS DISEASES BIOPHARMACEUTICALS MARKET  BREAKDOWN BY REGION, $M (2011 – 2014)

TABLE 32 GLOBAL  INFLAMMATORY AND INFECTIOUS DISEASES BIOPHARMACEUTICALS MARKET BREAKDOWN BY REGION, $M (2015 – 2020)

TABLE 33 GLOBAL  METABOLIC DISORDERS BIOPHARMACEUTICALS MARKET  BREAKDOWN BY REGION, $M (2011 – 2014)

TABLE 34 GLOBAL  METABOLIC DISORDERS BIOPHARMACEUTICALS MARKET  BREAKDOWN BY REGION, $M (2015 – 2020)

TABLE 35 GLOBAL  NEUROLOGICAL DISORDERS  BIOPHARMACEUTICALS MARKET   BREAKDOWN BY REGION, $M (2011 – 2014)

TABLE 36 GLOBAL NEUROLOGICAL DISORDERS  BIOPHARMACEUTICALS MARKET  BREAKDOWN BY REGION, $M (2015 – 2020)

TABLE 37 GLOBAL CARDIOVASCULAR BIOPHARMACEUTICALS MARKET  BREAKDOWN BY REGION, $M (2011 – 2014)

TABLE 38 GLOBAL CARDIOVASCULAR BIOPHARMACEUTICALS MARKET BREAKDOWN BY REGION, $M (2015 – 2020)

TABLE 39 NORTH AMERICA BIOPHARMACEUTICALS MARKET  BREAKDOWN BY TYPE, $M (2011 – 2014)

TABLE 40 NORTH AMERICA BIOPHARMACEUTICALS MARKET  BREAKDOWN BY TYPE, $M (2015 – 2020)

TABLE 41 NORTH AMERICA BIOPHARMACEUTICALS MARKET BREAKDOWN BY APPLICATION, $M (2011 – 2014)

TABLE 42 NORTH AMERICA BIOPHARMACEUTICALS MARKET  BREAKDOWN BY APPLICATION, $M (2015 – 2020)

TABLE 43 NORTH AMERICA BIOPHARMACEUTICALS MARKET  BREAKDOWN BY COUNTRY, $M (2011 – 2014)

TABLE 44 NORTH AMERICA  BIOPHARMACEUTICALS MARKET   BREAKDOWN BY COUNTRY, $M (2015 – 2020)

TABLE 45 EUROPE BIOPHARMACEUTICALS MARKET  BREAKDOWN BY TYPE, $M (2011 – 2014)

TABLE 46 EUROPE BIOPHARMACEUTICALS MARKET  BREAKDOWN BY TYPE, $M (2015 – 2020)

TABLE 47 EUROPE BIOPHARMACEUTICALS MARKET  BREAKDOWN BY APPLICATION, $M (2011 – 2014)

TABLE 48 EUROPE BIOPHARMACEUTICALS MARKET   BREAKDOWN BY APPLICATION, $M (2015 – 2020)

TABLE 49 EUROPE BIOPHARMACEUTICALS  MARKET  BREAKDOWN BY COUNTRY, $M (2011 – 2014)

TABLE 50 EUROPE BIOPHARMACEUTICALS  MARKET  BREAKDOWN BY COUNTRY, $M (2015 – 2020)

TABLE 51 ASIA BIOPHARMACEUTICALS MARKET  BREAKDOWN BY TYPE, $M (2011 – 2014)

TABLE 52 ASIA BIOPHARMACEUTICALS MARKET  BREAKDOWN BY TYPE, $M (2015 – 2020)

TABLE 53 ASIA BIOPHARMACEUTICALS MARKET  BREAKDOWN BY APPLICATION, $M (2011 – 2014)

TABLE 54 ASIA BIOPHARMACEUTICALS MARKET  BREAKDOWN BY APPLICATION, $M (2015 – 2020)

TABLE 55 ASIA BIOPHARMACEUTICALS MARKET  BREAKDOWN BY COUNTRY, $M (2011 – 2014)

TABLE 56 ASIA BIOPHARMACEUTICALS  MARKET   BREAKDOWN BY COUNTRY, $M (2015 – 2020)

TABLE 57 REST OF THE WORLD BIOPHARMACEUTICALS   MARKET   BREAKDOWN BY TYPE, $M (2011 – 2014)

TABLE 58 REST OF THE WORLD BIOPHARMACEUTICALS  MARKET  BREAKDOWN BY TYPE, $M (2015 – 2020)

TABLE 59 REST OF THE WORLD BIOPHARMACEUTICALS MARKET  BREAKDOWN BY APPLICATION, $M (2011 – 2014)

TABLE 60 REST OF THE WORLD BIOPHARMACEUTICALS  MARKET   BREAKDOWN BY APPLICATION, $M (2015 – 2020)

TABLE 61 REST OF THE WORLD BIOPHARMACEUTICALS  MARKET BREAKDOWN BY COUNTRY, $M (2011 – 2014)

TABLE 62 REST OF THE WORLD BIOPHARMACEUTICALS  MARKET  BREAKDOWN  BY COUNTRY, $M (2015 – 2020)

TABLE 63 ABBVIE INC. – KEY FACTS

TABLE 64 SANOFI – KEY FACTS

TABLE 65 ELI  LILLY  AND  COMPANY– KEY FACTS

TABLE 66 PFIZER INC. – KEY FACTS

TABLE 67 ABBOTT  LABORATORIES– KEY FACTS

TABLE 68 ASTRAZENECA PLC – KEY FACTS

TABLE 69 NOVARTIS AG – KEY FACTS

TABLE 70 BIOGEN  IDEC – KEY FACTS

TABLE 71 AMGEN INC. – KEY FACTS

TABLE 72 BRISTOL-MYERS  SQUIBB   COMPANY– KEY FACTS

TABLE 73 GLAXO SMITH KLINE PLC– KEY FACTS

TABLE 74 JOHNSON & JOHNSON  SERVICES INC. – KEY FACTS

TABLE 75 F. HOFFMANN-LA ROCHE  LTD – KEY FACTS

TABLE 76 MERCK & CO.,INC. – KEY FACTS

TABLE 77 BAYER  AG – KEY FACTS

 

LIST OF FIGURES

FIG 1 RESEARCH SCOPE FOR GLOBAL BIOPHARMACEUTICALS MARKET

FIG 2 RESEARCH METHODOLOGY FOR GLOBAL BIOPHARMACEUTICALS MARKET

FIG 3  AGING POPULATION AS A PERCENTAGE OF TOTAL POPULATION IN MAJOR COUNTRIES

FIG 4 GLOBAL BIOPHARMACEUTICALS MARKET SIZE BY TYPE, $M (2011-2020)

FIG 5 GLOBAL BIOPHARMACEUTICALS MARKET SHARE, BY TYPE (2014 AND 2020)

FIG 6 GLOBAL BIOPHARMACEUTICALS MARKET SIZE BY APPLICATION, $M (2011-2020)

FIG 7 GLOBAL BIOPHARMACEUTICALS MARKET SHARE, BY APPLICATION (2014 AND 2020)

FIG 8 GLOBAL BIOPHARMACEUTICALS  MARKET SIZE BY REGION, $M (2011-2020)

FIG 9 GLOBAL BIOPHARMACEUTICALS MARKET SHARE, BY REGION (2014 AND 2020)

FIG 10 BIOPHARMACEUTICALS MARKET SEGMENTATION BASED ON TYPE

FIG 11 GLOBAL MONOCLONAL  ANTIBODIES   MARKET SHARE, BY REGION (2014 AND 2020)

FIG 12 GLOBAL RECOMBINANT HUMAN INSULIN MARKET SHARE, BY REGION (2014 AND 2020)

FIG 13 GLOBAL COLONY STIMULATING FACTOR MARKET SHARE BY REGION (2014 AND 2020)

FIG 14  GLOBAL ERYTHROPOIETIN MARKET SHARE, BY REGION (2014 AND 2020)

FIG 15 GLOBAL VACCINES MARKET SHARE, BY REGION (2014 AND 2020)

FIG 16 GLOBAL GROWTH HORMONES MARKET SHARE, BY REGION (2014 AND 2020)

FIG 17 GLOBAL INTERFERONS MARKET SHARE, BY REGION (2014 AND 2020)

FIG 18 GLOBAL RECOMBINANT PROTEINS  MARKET SHARE, BY REGION (2014 AND 2020)

FIG 19 GLOBAL PURIFIED PROTEINS MARKET SHARE BY REGION (2014 AND 2020)

FIG 20 BIOPHARMACEUTICALS  MARKET SEGEMTATION BASED ON  APPLICATION

FIG 21 GLOBAL ONCOLOGY BIOPHARMACEUTICALS MARKET SHARE, BY REGION (2014 AND 2020)

FIG 22 GLOBAL  INFLAMMATORY AND INFECTIOUS DISEASES BIOPHARMACEUTICALS MARKET SHARE, BY REGION (2014 AND 2020)

FIG 23 GLOBAL  METABOLIC  DISORDERS BIOPHARMACEUTICALS MARKET SHARE, BY REGION (2014 AND 2020)

FIG 24 GLOBAL  NEUROLOGICAL DISORDERS BIOPHARMACEUTICALS MARKET SHARE, BY REGION (2014 AND 2020)

FIG 25 GLOBAL CARDIOVASCULAR BIOPHARMACEUTICALS MARKET SHARE, BY REGION (2014 AND 2020)

FIG 26 GLOBAL BIOPHARMACEUTICALS  MARKET, BY COUNTRY (2020)

FIG 27 NORTH AMERICA BIOPHARMACEUTICALS MARKET SHARE, BY TYPE (2014 AND 2020)

FIG 28 NORTH AMERICA BIOPHARMACEUTICALS  MARKET SHARE, BY APPLICATION   (2014 AND 2020)

FIG 29 NORTH AMERICA BIOPHARMACEUTICALS MARKET SHARE, BY COUNTRY (2014 AND 2020)

FIG 30  EUROPE BIOPHARMACEUTICALS MARKET SHARE BY TYPE (2014 AND 2020)

FIG 31  EUROPE BIOPHARMACEUTICALS  MARKET SHARE, BY APPLICATION (2014 AND 2020)

FIG 32 EUROPE BIOPHARMACEUTICALS MARKET SHARE, BY COUNTRY (2014 AND 2020)

FIG 33  ASIA BIOPHARMACEUTICALS MARKET SHARE, BY TYPE (2014 AND 2020)

FIG 34  ASIA BIOPHARMACEUTICALS  MARKET SHARE, BY APPLICATION (2014 AND 2020)

FIG 35 ASIA BIOPHARMACEUTICALS MARKET SHARE, BY COUNTRY (2014 AND 2020)

FIG 36  REST OF THE WORLD BIOPHARMACEUTICALS MARKET SHARE, BY TYPE (2014 AND 2020)

FIG 37  REST OF THE WORLD BIOPHARMACEUTICALS  MARKET SHARE, BY APPLICATION   (2014 AND 2020)

FIG 38 REST OF THE WORLD BIOPHARMACEUTICALS MARKET SHARE, BY COUNTRY (2014 AND 2020)

FIG 39 PORTER’S FIVE FORCES OF COMPETITIVE POSITION ANALYSIS

FIG 40 GLOBAL BIOPHARMACEUTICALS MARKET SHARE, BY COMPANY (2014)

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 5100
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 6100
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 9100

Pre-Purchase Enquiry